Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF – Get Free Report) shares fell 14.6% during mid-day trading on Thursday . The company traded as low as $11.91 and last traded at $11.91. 18,064 shares changed hands during mid-day trading, an increase of 1,706% from the average session volume of 1,000 shares. The stock had previously closed at $13.95.
Surgical Science Sweden AB (publ) Stock Performance
The stock’s 50 day simple moving average is $14.01 and its 200 day simple moving average is $13.04.
Surgical Science Sweden AB (publ) Company Profile
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.
See Also
- Five stocks we like better than Surgical Science Sweden AB (publ)
- 3 Fintech Stocks With Good 2021 Prospects
- Darden Stock Up After Q4 Earnings Beat, Cautious FY25 Outlook
- What is Put Option Volume?
- Celsius Stock: Why Piper Sandler Forecasts a 50% Surge
- Roth IRA Calculator: Calculate Your Potential Returns
- Accenture’s Stock Earnings Reveal an AI-Powered Growth Strategy
Receive News & Ratings for Surgical Science Sweden AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Science Sweden AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.